White House: It is unacceptable for states to restrict access to abortion pills

Published Date: 08 Mar 2023

The White House said Friday it was "dangerous and unacceptable" for elected officials to target women's access to federally-approved abortion pills.

Read Full News

Latest News

Menstruation topic still stigmatized by younger generation in Spain, study finds

The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint center of the Spanish National Research Council ...

Research team develops actionable tool to assess risk for premature births

Researchers at NYU and partners within the International Healthy Outcomes of Pregnancy for Everyone (HOPE) Consortium have developed a novel tool, the Preterm Birth Actionable Risk Index (PTB-ARIx), designed to identify pregnant ...

AHA: Study examines impact of adequate prenatal care for congenital heart disease

For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a cardiac center, according to a study published online Nov. 9 in JAMA Network Open to coincide ...

Severe nausea during pregnancy and depression: Study reveals bidirectional association

A recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more ...

Common cesarean closure method linked to long-term complications, experts suggest change

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two world-renowned specialists in ...

From post-partum depression to relationship woes: The importance of mental health after giving birth

"Postpartum depression" has been discussed as an identifiable, measurable, treatable disorder for 50 years now. Thresholds, scales, prevalence rates: everything seems clear, even reassuring.

Todays Updates

Phase 3b STRENGTH Trial Provides Greater Support for Intrathecal SMA Gene Therapy Marco Meglio

Phase 3b study revealed Itvisma's safety and efficacy in treating spinal muscular atrophy, showing modest motor function improvements in patients previously on other therapies.

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

Renal Transplantation May Lower Sleep Disorder Risk Versus Dialysis

Renal Transplantation May Lower Sleep Disorder Risk Versus Dialysis

BMI, Inflammatory Bowel Disease Both Show Causal Effect on HS Development

BMI, Inflammatory Bowel Disease Both Show Causal Effect on HS Development

The HCPFive: Top News for Healthcare Providers from the Week of 12/14

The HCPFive: Top News for Healthcare Providers from the Week of 12/14

Todays Updates

Phase 3b STRENGTH Trial Provides Greater Support for Intrathecal SMA Gene Therapy Marco Meglio

Phase 3b study revealed Itvisma's safety and efficacy in treating spinal muscular atrophy, showing modest motor function improvements in patients previously on other therapies.

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

Renal Transplantation May Lower Sleep Disorder Risk Versus Dialysis

Renal Transplantation May Lower Sleep Disorder Risk Versus Dialysis

BMI, Inflammatory Bowel Disease Both Show Causal Effect on HS Development

BMI, Inflammatory Bowel Disease Both Show Causal Effect on HS Development

The HCPFive: Top News for Healthcare Providers from the Week of 12/14

The HCPFive: Top News for Healthcare Providers from the Week of 12/14

Latest News

The menstrual taboo persists. This is the main conclusion of a pioneering macro-study in Spain involving more than 4,000 participants and led by the INGENIO Institute, a joint center of the Spanish National Research Council ...

Researchers at NYU and partners within the International Healthy Outcomes of Pregnancy for Everyone (HOPE) Consortium have developed a novel tool, the Preterm Birth Actionable Risk Index (PTB-ARIx), designed to identify pregnant ...

For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a cardiac center, according to a study published online Nov. 9 in JAMA Network Open to coincide ...

A recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more ...

The most common technique used for closing the uterus after a cesarean delivery causes so many long-term complications that it's time to question its use. That's the conclusion reached by two world-renowned specialists in ...

"Postpartum depression" has been discussed as an identifiable, measurable, treatable disorder for 50 years now. Thresholds, scales, prevalence rates: everything seems clear, even reassuring.

News All Time

New study shows long-term effectiveness of HPV vaccine

A new study has confirmed that the human papillomavirus (HPV) vaccine provides strong and sustained protection against cervical disease that can develop into cancer.

Exercise reduces risk of common postpartum pelvic floor problems

Targeted pelvic floor muscle training in the first year postpartum significantly reduces the risk of two common pelvic floor disorders, according to a study that rewrites the longstanding narrative that these disorders are ...

Problems with regulating emotions during pregnancy may help predict perinatal depression

Around 1 in 5 mothers experience perinatal depression. This condition involves depressive episodes during pregnancy or just after birth—often with lasting effects on both mother and child.

Sugar–protein interactions, critical for placenta during early pregnancy, shed light on common complications

During the first weeks of pregnancy, the developing placenta in a mother's womb undergoes a dramatic change. Individual cells merge, forming a continuous barrier that will spend the next nine months ferrying oxygen and nutrients ...

The quiet collapse of America's reproductive health safety net

In late October, Maine Family Planning announced three rural clinics in northern Maine would close by month's end. These primary care and reproductive health clinics served about 800 patients, many uninsured or on Medicaid.

Meta-analysis evaluates effectiveness of various psychological therapies for perinatal depression

A systematic review and meta-analysis evaluated the effectiveness of psychological therapies for perinatal depression, the most prevalent maternal mental health disorder. The review, published in the Annals of Internal Medicine, ...

Wildfire smoke exposure during pregnancy linked to higher risk of preterm birth

About 10% of American babies are born prematurely. Birth before 37 weeks can lead to a cascade of health risks, both immediate and long-term, making prevention a vital tool for improving public health over generations.

Back pain during pregnancy is often dismissed as a passing discomfort—a nurse explains why it should be taken seriously

About half to three-quarters of expectant mothers experience pain during pregnancy that is largely untreated, contributing to preventable suffering and harm. Many mothers avoid medications and treatments during pregnancy ...

Researchers discuss gaps, obstacles and solutions for contraception

Contraception and family planning are vital aspects of sexual and reproductive health and rights. Despite major advances in modern contraception over the past 60 years, many gaps remain and the rate of unplanned pregnancies ...

COVID-19 during pregnancy linked to higher risk of neurodevelopmental disorders in children

Children born to mothers who had COVID-19 while pregnant face an elevated risk of developmental disorders by the time they turn 3 years old, including speech delays, autism, motor disorders, and other developmental delays, ...

Safeguarding fertility: Study investigates key hormone for women with cancer choosing fertility preservation

Newly diagnosed female cancer patients of reproductive age have a very short window for storing their eggs and embryos before starting cancer treatment. This is a process known as fertility preservation (FP), which protects ...

Breast cancer risk varies between different hormonal contraceptives, research reveals

Some common hormonal contraceptives are linked to a slightly higher risk of breast cancer than others. This is shown by a Swedish study from Uppsala University, in which researchers followed more than two million women and ...

Punitive drug laws may deter prenatal care and hospital-based delivery

States that explicitly criminalize prenatal drug use may unintentionally discourage pregnant people from seeking essential medical care, according to new research from Columbia University Mailman School of Public Health. ...

Highlighting key therapies that support women through high-risk pregnancies 

Joint research from Edith Cowan University (ECU) and the University of St. Augustine for Health Sciences, in the US, is shedding new light on the broader potential of psychosocial occupational therapy, revealing it can play ...

Study shows Australian preterm birth prevention program is working

New data has shown that an initiative to reduce preterm births in Australia has led to a significant decrease in rates of potentially harmful early birth and improved pregnancy outcomes for women across the country.

Vitamin D deficiency increases risk of complicated deliveries, finds study

A research team at Uppsala University has identified a clear link between osteomalacia—a form of bone softening commonly caused by vitamin D deficiency—and a fivefold increased risk of emergency cesarean sections or the ...

Recommended News For You

Alkem introduces cetuximab under the trade name Cetuxa in India.

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

Psychiatric Disorders Are Common in Dementia Patients.

Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.

Should the UK introduce targeted prostate cancer screening? The case for and against

FDA Bans Red Dye No. 3 From Foods, Ingested Drugs

Recommended Articles For You

Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits 

Unlocking The Causes And Risk Factors Of Breast Cancer 

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care 

Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.

2.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

3.

MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information

4.

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines

5.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

1.

Advancements in Cancer Treatment and Survival Outcomes for Acute Myeloid Leukemia

2.

Integrative Clinical Genomics of Metastatic Cancer: Decoding Tumor Evolution for Precision Oncology

3.

Unraveling the Mysteries of Hematocrit: How It Impacts Your Health

4.

What is Hemorrhagic Cystitis and How to Manage its Symptoms

5.

Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

2.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

3.

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD

4.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

5.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot